These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16364488)

  • 1. Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
    Larter CZ; Farrell GC
    J Hepatol; 2006 Feb; 44(2):253-61. PubMed ID: 16364488
    [No Abstract]   [Full Text] [Related]  

  • 2. Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease.
    Bianchi G; Bugianesi E; Frystyk J; Tarnow L; Flyvbjerg A; Marchesini G
    Dig Liver Dis; 2011 Jan; 43(1):73-7. PubMed ID: 20554486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
    Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP
    Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of nonalcoholic fatty liver disease with serum adiponectin and insulin resistance].
    Shi SL; Nie YQ; Li YY; Zhou YJ; Ma JX
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):58-9. PubMed ID: 17244464
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
    Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S
    Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance.
    Tilg H; Hotamisligil GS
    Gastroenterology; 2006 Sep; 131(3):934-45. PubMed ID: 16952562
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic steatosis, visceral adiposity, insulin resistance, adiponectin, and inflammation.
    Tasci I; Erdem G; Sonmez A; Dogru T; Ercin CN
    Metabolism; 2009 Jan; 58(1):141; author reply 142. PubMed ID: 19059541
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    Cave M; Deaciuc I; Mendez C; Song Z; Joshi-Barve S; Barve S; McClain C
    J Nutr Biochem; 2007 Mar; 18(3):184-95. PubMed ID: 17296492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss.
    Lin E; Phillips LS; Ziegler TR; Schmotzer B; Wu K; Gu LH; Khaitan L; Lynch SA; Torres WE; Smith CD; Gletsu-Miller N
    Diabetes; 2007 Mar; 56(3):735-42. PubMed ID: 17327444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non alcoholic fatty liver].
    Delgadillo AT
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():104-5. PubMed ID: 17037790
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased high-molecular weight adiponectin-to-total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance.
    Katsuki A; Suematsu M; Gabazza EC; Murashima S; Nakatani K; Togashi K; Yano Y; Sumida Y
    Diabetes Care; 2006 Oct; 29(10):2327-8. PubMed ID: 17003319
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms.
    Engl J; Sturm W; Sandhofer A; Kaser S; Tschoner A; Tatarczyk T; Weiss H; Tilg H; Patsch JR; Ebenbichler CF
    Eur J Clin Invest; 2008 Apr; 38(4):238-44. PubMed ID: 18312420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth.
    Kim ES; Im JA; Kim KC; Park JH; Suh SH; Kang ES; Kim SH; Jekal Y; Lee CW; Yoon YJ; Lee HC; Jeon JY
    Obesity (Silver Spring); 2007 Dec; 15(12):3023-30. PubMed ID: 18198311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum acylated ghrelin, adiponectin and leptin levels in normal-weight and obese premenopausal women.
    Krzyzanowska-Swiniarska B; Kempa A; Miazgowski T; Pilarska K
    Horm Metab Res; 2007 Nov; 39(11):835-9. PubMed ID: 17992641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NASH and cardiovascular biomarkers.
    Ercin CN; Dogru T; Tasci I; Erdem G; Sonmez A; Tapan S
    Obesity (Silver Spring); 2009 Apr; 17(4):627; author reply 627. PubMed ID: 19322144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.